top of page
Arstat Pharmaceuticals is preparing for an H1 2027 Nasdaq
listing. We provide investor materials to qualified partners who align with our long‑term vision and the scale of the opportunity.
Investment Overview (Summary Graphic)
To request information regarding Arstat Pharmaceuticals investment opportunity, please contact:
bottom of page